Education
Poster Abstracts
Poster Abstracts
Sponsored by:
| Presenter | Abstract Title |
|---|---|
| Resident Regina Hayburn | A DESCRIPTIVE STUDY OF HEAD AND NECK TUMORS IN YOUNG DOGS |
| Shirley Chu | A MULTI-INSTITUTIONAL EPIDEMIOLOGIC STUDY EVALUATING ENVIRONMENTAL RISK FACTORS FOR FELINE ORAL SQUAMOUS CELL CARCINOMA |
| Resident Emily Janik | A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF CANINE HEPATOCELLULAR CARCINOMA |
| Margo Coxon | ASSESSMENT OF CANINE AND EQUINE APOBEC3A HOMOLOGS MUTAGENIC ACTIVITY |
| Andi Flory | BLOOD-BASED LIQUID BIOPSY USING NEXT-GENERATION SEQUENCING FOR THE DETECTION OF SPLENIC MALIGNANCIES |
| Aaron Offerman | CANINE AND HUMAN OSTEOSARCOMA CELL CO-CULTURE WITH PRIMARY LUNG FIBROBLASTS MODULATES SENSITIVITY TO STANDARD-OF-CARE CHEMOTHERAPY |
| Esther Chon | CANINE LYMPHOMA GENOMIC LANDSCAPE AND CLINICAL ACTIONABILITY |
| Rachel Brady | CD206 AGONISM STIMULATES GROWTH OF HISTIOCYTIC SARCOMA CELL LINES |
| Resident Ellen Kuerbitz | CHARACTERIZATION OF GENE EXPRESSION SIGNATURES IN THE URINE OF DOGS WITH INVASIVE UROTHELIAL CARCINOMA |
| Matheus Moreno Passos Barbosa | CHARACTERIZING IMMUNE INFILTRATES AND ASSOCIATED TRANSCRIPTOMICS IN CANINE ORAL MALIGNANT MELANOMA TO GUIDE THERAPEUTIC INTERVENTIONS |
| Patricia Filippsen Favaro | CIRCULATING TUMOR DNA ANALYSIS IN PET DOGS WITH NATURALLY-OCCURRING SARCOMAS |
| Tin-Wei Yu | COMPARATIVE PHARMACOKINETIC PROFILE OF TYROSINE KINASE INHIBITOR, LAPATINIB, IN DOGS AND CATS |
| William Kisseberth | CT EVALUATION OF METASTATIC LYMPH NODES IN DOGS WITH APOCRINE GLAND ANAL SAC ADENOCARCINOMA AND ITS EFFECT ON PROGNOSIS |
| Brian Flesner | DETECTION AND GENOMIC PROFILING OF CANINE SARCOMAS BY NEXT-GENERATION SEQUENCING-BASED LIQUID BIOPSY |
| Resident Lydia Sixta | DETECTION OF TUMOR-ASSOCIATED BACTERIAL DNA (MICROBIOME) WITHIN CANINE MELANOMA AND OSTEOSARCOMA USING THE BACTERIAL 16S RIBOSOMAL RNA GENE |
| Takeshi Kawakami | DEVELOPMENT AND VALIDATION OF AN ANCESTRY-BASED GENETIC PREDICTIVE MODEL FOR MAST CELL TUMOR RISK AMONG BULLY BREEDS |
| Pamela Jones | DIAGNOSTIC VIABILITY OF CANINE MAST CELL TUMOUR TISSUE BIOPSY SAMPLES ACQUIRED 5-10 MINUTES POST-TIGILANOL TIGLATE TREATMENT |
| Corrine Thomas | DISCOVERY OF TARGET ANTIGENS FOR IMMUNE-BASED THERAPY IN CANINE HEMANGIOSARCOMA THROUGH SYSTEMIC SURFACEOME PROFILING |
| Resident Alana Kuzmik | DOPAMINE SIGNALING PROTEIN EXPRESSION IN CANINE LUNG ADENOCARCINOMA |
| Hirona Ueno | EFFICACY AND SAFETY OF RE-IRRADIATION AFTER HYPOFRACTIONATED RADIOTHERAPY FOR INTRANASAL TUMORS IN DOGS |
| Shinichiro Yoda | ENVIRONMENTAL CONSIDERATIONS IN VETERINARY RADIOTHERAPY USING REUSABLE CYLINDERS FOR HEAD IMMOBILIZATION |
| Ryohei Kinoshita | ESTABLISHMENT OF PATIENT-DERIVED XENOGRAFT MODELS OF CANINE TRANSITIONAL CELL CARCINOMA AND PROSTATE CANCER |
| Resident Zoe Williams | FREQUENCY OF MANDIBULAR AND SUPERFICIAL CERVICAL LYMPH NODE METASTASIS IN DOGS WITH THYROID CARCINOMA |
| Resident Andy Hsueh | HEEV: HISTOTRIPSY-ENABLED EXTRACELLULAR VESICLE CHARACTERIZATION IN CANINE SOFT TISSUE SARCOMA PATIENTS |
| Josephine Tsang | IDENTIFICATION OF DRUG RESPONSE BIOMARKERS FOR CANINE LYMPHOMA IN LARGE-SCALE NGS SCREEN |
| Gabriela Rojas Ibarra | INCIDENCE OF MAST CELL TUMORS IN DOGS IN MEXICO CITY (NATIONAL AUTONOMOUS UNIVERSITY OF MEXICO) FROM 2017 TO 2022 |
| Daniel Gustafson | INHIBITION OF CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE (CHD1L) AS A TREATMENT STRATEGY IN CANINE OSTEOSARCOMA |
| Janice Viary | INVESTIGATING THE ROLE OF GLUTAMATE SIGNALLING IN CANINE HEMANGIOSARCOMA PROLIFERATIVE BIOLOGY |
| Yuan Xin Roxanna Neo | IS THERE A ROLE FOR PERIPHERAL LEUKOCYTE RATIOS AND SYSTEMIC INFLAMMATION INDICES IN MANAGEMENT OF CANINE CUTANEOUS MAST CELL TUMORS? |
| Resident Molly Gasparini | LABORATORY ACUTE TUMOR LYSIS SYNDROME IN DOGS |
| Do yun Kim | LAPATINIB TREATMENT FOR REFRACTORY MALIGNANT TUMORS IN DOGS AND CATS |
| Peter Bennett | LYMPHOMA OUTCOMES IN AUSTRALIAN CATS - 732 CASES (2000 - 2022) |
| Resident Diana Sanchez | MECHANISMS OF CHOP TREATMENT RESISTANCE IN CANINE DIFFUSE LARGE B CELL LYMPHOMA |
| Takamitsu Kato | MECHANISMS OF RADIO- AND CHEMO- SENSITIZATION EFFECTS OF SQAP |
| Yuta Nishiyama | PHASE I/II TRIALS OF THREE TIMES WEEKLY TREATMENT WITH TEYSUNO (TEGAFUR/GIMERACIL/OTERACIL) AND PALLADIA (TOCERANIB PHOSPHATE) IN DOGS |
| Shoma Koseki | PODOPLANIN EXPRESSED ON CANCER-ASSOCIATED FIBROBLASTS INHIBITED ANTI-TUMOR IMMUNE RESPONSE |
| Lucas Rodriges | REAL-WORLD DATA ANALYSES OF CANINE OSTEOSARCOMA MUTATION AND TREATMENT OUTCOME USING MACHINE LEARNING |
| Resident Vivian Fan | RETROSPECTIVE ANALYSIS OF CARBOPLATIN INDUCED CUMULATIVE NEUTROPENIA IN CANCER BEARING DOGS |
| Resident Kelly Hicks | RETROSPECTIVE EVALUATION OF TOCERANIB PHOSPHATE (PALLADIA®) IN THE TREATMENT OF CANINE CARCINOMATOSIS AND MESOTHELIOMA |
| Resident Samantha Beeson | RNA-SEQ ANALYSIS TO EXPLORE THE DIVERSITY OF MOLECULAR TARGETS IN CANINE HISTIOCYTIC SARCOMA |
| Resident Whitney Wyatt | SALIVARY ANALYSIS IN DOGS TREATED WITH DEFINITIVE RADIATION THERAPY FOR HEAD AND NECK CANCER |
| Resident Alexandra Gareau | SERUM SDMA AS A PREDICTOR OF TOXICITY OF CARBOPLATIN IN DOGS |
| Haru Yamamoto | SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CHARACTERISTICS OF FELINE MAMMARY TUMOR ORGANOID |
| Resident Patricia Gualtieri | STEREOTACTIC BODY RADIATION THERAPY FOR ORAL TUMORS IN CANINE PATIENTS |
| Zachary Lewis | TECHNICAL DIFFICULTIES: STANDARDIZING METHODS FOR CHARACTERIZING THE CANINE UROBIOME |
| Daniel York | THE ARYL HYDROCARBON RECEPTOR PROMOTES CHEMORESISTANCE IN CANINE OSTEOSARCOMA CELLS |
| Jessica Sharpe | THE EPHB4 RECEPTOR REGULATES THE INVASIVENESS AND TUMOR INITIATION OF CANINE AND HUMAN OSTEOSARCOMA |
| Todd Cohen | THE IMPACT OF GLUCOCORTICOID USE AT THE TIME OF BLOOD DRAW ON NEXT-GENERATION SEQUENCING-BASED LIQUID BIOPSY RESULTS IN DOGS WITH LYMPHOID NEOPLASIA |
| Lisa Parshley | THYROID STIMULATING HORMONE ELEVATION IN CANINE THYROID TUMOR PATIENTS: POTENTIAL STAGING AND THERAPEUTIC IMPLICATIONS |
| Resident Evangelia Makrygiannis | TOXICITY AND PRELIMINARY EFFICACY OF FIXED DOSE RATE GEMCITABINE IN DOGS WITH NEOPLASIA |
| Jeffrey Bryan | TRANSLATING A CANCER-AGNOSTIC SCREENING PET AGENT SYSTEM IN DOGS FOR EARLY DETECTION OF CANCER IN HUMANS |
| Olivier Keravel | TREATMENT OF FELINE FIBROSARCOMA WITH WIDE SURGICAL EXCISION AND INTRAOPERATIVE ORTHOVOLTAGE 300KV (33 CASES WITH 3 YEARS MINIMUM FOLLOW UP): AN OPPORTUNITY FOR THERAPEUTIC DE-ESCALATION? |
| Jeong-Hwa Lee | TSG-6 KNOCK-OUT IMPROVES THERAPEUTIC EFFICACY OF CELL VACCINE AGAINST MOUSE MODEL FOR TRIPLE-NEGATIVE BREAST CANCER |
| Katherine Megquier | WHOLE GENOME SEQUENCING OF CANINE HEMANGIOSARCOMA TUMORS AND CELL-FREE DNA |